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Background: Evidence suggests that exercise training improves CVD risk factors. However, it is unclear whether
health benefits are limited to aerobic training or if other exercise modalities such as resistance training or a
combination are as effective or more effective in the overweight and obese. The aim of this study is to investigate
whether 12 weeks of moderate-intensity aerobic, resistance, or combined exercise training would induce and
sustain improvements in cardiovascular risk profile, weight and fat loss in overweight and obese adults compared
to no exercise.
Methods: Twelve-week randomized parallel design examining the effects of different exercise regimes on fasting
measures of lipids, glucose and insulin and changes in body weight, fat mass and dietary intake. Participants were
randomized to either: Group 1 (Control, n = 16); Group 2 (Aerobic, n = 15); Group 3 (Resistance, n = 16); Group 4
(Combination, n = 17). Data was analysed using General Linear Model to assess the effects of the groups after
adjusting for baseline values. Within-group data was analyzed with the paired t-test and between-group effects
using post hoc comparisons.
Results: Significant improvements in body weight (−1.6%, p = 0.044) for the Combination group compared to
Control and Resistance groups and total body fat compared to Control (−4.4%, p = 0.003) and Resistance
(−3%, p = 0.041). Significant improvements in body fat percentage (−2.6%, p = 0.008), abdominal fat percentage
(−2.8%, p = 0.034) and cardio-respiratory fitness (13.3%, p = 0.006) were seen in the Combination group compared
to Control. Levels of ApoB48 were 32% lower in the Resistance group compared to Control (p = 0.04).
Conclusion: A 12-week training program comprising of resistance or combination exercise, at moderate-intensity
for 30 min, five days/week resulted in improvements in the cardiovascular risk profile in overweight and obese
participants compared to no exercise. From our observations, combination exercise gave greater benefits for weight
loss, fat loss and cardio-respiratory fitness than aerobic and resistance training modalities. Therefore, combination
exercise training should be recommended for overweight and obese adults in National Physical Activity Guidelines.
This clinical trial was registered with the Australian New Zealand Clinical Trials Registry (ANZCTR), registration
number: ACTRN12609000684224.
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Figure 1 Participant flow chart.
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Physical activity is a major modifiable determinant of
chronic disease [1]. The Australian National Physical
Activity Guidelines for Adults recommend that for good
health, adults should “put together at least 30 min of
moderate-intensity physical activity on most, preferably
all, days [2].” However, it is not known if this recom-
mendation is adequate for improvement in cardiovascu-
lar disease (CVD) risk factors in overweight and obese
individuals [3]. Despite the acknowledged role of 30 min-
utes of daily physical activity on general health improve-
ments in an otherwise healthy but sedentary population,
less is known of the adequacy of this level of exercise for
health improvements in those who are overweight or
obese. In addition, as many people have difficulty finding
time to exercise, it is important to better understand
which mode(s) of exercise is the most effective.
Numerous studies have investigated the effects of exer-
cise training, demonstrating significant improvements to
CVD risk factors after aerobic exercise training [4,5].
However, it is unclear whether health benefits are lim-
ited to aerobic training or if other exercise modalities
such as resistance training or a combination are as ef-
fective or more effective in the overweight and obese.
Sigal et al. [6] investigated the effects of aerobic, resist-
ance and combined aerobic and resistance training in
adults with Type 2 diabetes. However, the combined
intervention used both aerobic (45-min walking/cycling)
plus resistance training (2–3 sets of 7 exercises with 7–9
repetitions), that is, participants completed a double dose
of exercise. They observed significant decreases in body
weight, body mass index (BMI) and abdominal subcuta-
neous fat in the aerobic and resistance groups compared
to control.
Davidson et al. [7] also examined different exercise
modalities in older adults. Calorie intake was strictly
controlled and results were due solely to the energy def-
icit of the exercise interventions. They observed signifi-
cant improvements to total, abdominal and visceral fat
and cardio-respiratory fitness in the aerobic and combin-
ation exercise groups. It was concluded that the combin-
ation of the resistance and aerobic exercise was the
optimal exercise strategy for improvements to insulin re-
sistance and functional limitations [7].
A recent study by Church et al. [8] compared equiva-
lent time durations (140 min/week) of aerobic, resistance
and combination exercise. They observed significant
improvements in HbA1c and maximum oxygen con-
sumption in the combination group compared to control
as well as decreases in weight and fat mass in the resist-
ance and combination groups compared to control.
Research comparing the effect of resistance and aerobic
training on CVD risk factors is limited and few studies
have compared aerobic, resistance and a combination ofthis training. Given the increasing burden of chronic dis-
ease, more research is needed to better understand the
effect of different exercise modalities on these risk fac-
tors. Australian Physical Activity Guidelines promote
30-min of moderate-intensity exercise on most days of
the week; therefore the aim of this study was to inves-
tigate whether a 12-week training program with aerobic,
resistance, or combined exercise at the same intensity
and duration would improve the cardiovascular risk




Ninety-seven overweight or obese men (n = 16) and
women (n = 81) (BMI >25 kg/m2 or waist circumference
>80 cm for women and 90 cm for men), aged 40 to 66 y
were recruited from the general population from April
2006 - April 2007 (Figure 1). Participants were required
to be sedentary or relatively inactive, participating in less
than 1 h of moderate-intensity physical activity per week
over the last 3 months. Participants were recruited from
an existing database of volunteers from previous studies
that concluded at least 6 months prior and from the
community using local newspapers and radio. Interested
individuals were screened via telephone. Exclusion cri-
teria included diabetes mellitus, pre-existing heart condi-
tions, lipid lowering medication, beta-blockers, pregnant
or lactating women, smokers, gastrointestinal tract sur-
gery, major illness (acute or chronic) including any that
would limit the ability to perform the necessary exercises.
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sity Ethics Committee (HR 166/2004) and participants
gave written informed consent.
Study design
This 12-week study was a randomized parallel design
examining the effects of different exercise regimes on
fasting measures and changes in body weight, fat mass
and dietary intake. Participants were randomized to four
different groups as they were recruited by the researcher
(using a randomization sequence [9]). Group 1 (Control)
were not given any exercise intervention (placebo dietary
supplement only). This was to ensure participants did
not know they were in the control group and followed
study procedures similarly to those in the intervention
groups. Control participants were asked to take a tea-
spoon of supplement in a glass of water once/day which
contained approximately 2 grams breadcrumbs and 0.1
grams “Equal” artificial sweetener. Group 2 (Aerobic)
performed 30-min of aerobic exercise, 5 days/week, con-
sisting of treadmill walking. Group 3 (Resistance) per-
formed 30-min of resistance exercise, 5 days/week using
weight resistance machines. Group 4 (Combination)
performed 15-min of aerobic and 15-min of resistance
exercise 5 days/week. Three assessment visits were con-
ducted in clinical rooms at Curtin University for blood
samples, body composition and other measurements. All
participants were requested to keep food intake and
physical activity the same as before the study, except for
those in the exercise groups, who were instructed to do
additional exercise as per their program. Participants
completed baseline measurements over one week before
attending an initiation session at the Curtin Fitness
Centre where their exercise program was demonstrated
by Centre staff.
Exercise interventions
The exercise interventions were either 30-min aerobic
exercise on a treadmill at 60% heart rate reserve (HRR)
±10 beats/min, with HRR estimated using the Karvonen
equation (220-age-resting heart rate) [10]; 30-min of re-
sistance exercise (four sets of 8–12 repetitions at 10-RM
for leg press, leg curl, leg extension, bench press and
rear deltoid row, with each set completed in approxi-
mately 30-sec with 1-min rest) with the 10-RM level
determined during the initial session by Fitness Centre
staff; or a combination of 15-min aerobic exercise and
15-min of resistance exercise (two sets of each exercise).
10-RM would be approximately 75% of 1-RM [11]. Start-
ing workload levels for each piece of equipment were
tested by participants and if more than 10 repetitions
were achieved, the weight was increased and after a
short rest participants tried again. Likewise, if less than 8
repetitions were achieved, the weight was decreased andafter a short rest participants tried again. Participants
began by exercising three days/week for two weeks be-
fore exercising at recommended levels for five days/week
thereafter. Participants reported to the Curtin Fitness
Centre three days/week to complete the required exer-
cise and either exercised at home the other two days or
at the Centre. If exercises were completed at home,
dumbbells (adjustable weight 1.5-10.5 kg) were provided
for resistance exercises (three sets of 10 repetitions for
biceps curls, lunges, dumbbell raise, calf lift, triceps ex-
tension for Resistance group while the Combination
group did 2 sets of biceps curls and lunges and 1 set for
dumbbell raise, calf lift and triceps extension; back ex-
tension, push ups and sit ups exercises were also in-
cluded). Treadmills were equipped with heart rate
sensors and participants were instructed to increase
weight loads by 2.5 kg increments when they could
complete more than 12 repetitions. Participants kept
food diaries to monitor dietary intake and were given
instructions during the briefing session. Data was ana-
lysed with Foodworks Professional 2007, Xyris Software,
Australia.
Measurement of biochemical markers
Participants reported for fasting blood samples at base-
line and at the completion of 8 and 12 weeks of training.
Serum triglyceride (TG) and total cholesterol were mea-
sured by enzymatic colorimetric kits (TRACE Scientific
LTD, Melbourne, Australia). High density lipoprotein
(HDL)-cholesterol was determined after precipitation of
apoB-containing lipoproteins with phosphotungstic acid
and MgCl2 [12]. Low density lipoprotein (LDL)-choles-
terol was determined using a modified version of the
Friedewald equation [13]. Non-esterified fatty acid was
determined in serum using the WAKO NEFA C Kit
(Wako Pure Chemicals Industries, Osaka, Japan) accord-
ing to instructions, but scaled down 1:10 to use on
microtiter plates. Plasma glucose was measured using
Randox glucose GOD-PAP kits (Randox, Antrim, United
Kingdom). Plasma insulin was measured by a solid phase
Enzyme Amplified Sensitivity Immunoassay (INS-EASIA
kit, BioSource, Belgium). Homeostasis model assessment
of insulin resistance (HOMA2-IR) was calculated from
fasting glucose and insulin concentrations [14].
Anthropometric measures
Anthropometric measures were completed and BMI cal-
culated. Weight was measured using electronic scales
(Tanita Corporation, Tokyo, Japan). Waist circumference
was measured at the mid-point between the bottom of
the rib cage and the iliac crest and hip circumference
was measured at the widest point at the hip. Abdominal
and total body fat was measured by DXA (dual-energy
X-ray absorptiometry) at baseline and 12 weeks (GE-Lunar
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UK). The analysis program automatically defines the
abdominal fat region with a rectangle from the upper
edge of the second lumbar vertebra extended to the lower
edge of the fourth lumbar vertebra.
Apolipoprotein B48 determination
Plasma samples and purified apoB48 standards (previ-
ously prepared according to Zilversmit and Shea [15])
were separated by SDS-PAGE using precast NuPAGE
3-8% gradient gels in a Novex Mini-Cell (Novex Instru-
ments, CA, USA) at 150 V for 80 min as described pre-
viously [16]. Separated proteins were electro-transferred
at 30 V for 90 min onto 0.45 μm polyvinylidine diflour-
ide (PVDF) membrane. Membranes were blocked over-
night at 4 °C in TBST (tris-buffered saline with Tween-
20) (10 mmol/L Tris–HCl buffer, pH 7.4, containing
154 mmol/L NaCl) and 10% (w/v) skim milk powder.
After washing in TBST, membranes were incubated withTable 1 Participant characteristics at baseline
Characteristic Control (n = 16) Aerob
Male/Female 1/15 3/12
Age (years) 52 ± 1.8 55 ± 1
(40 – 66) (44 –
Weight (kg) 85.1 ± 4.2 91.9 ±
(64.8 – 123) (65.9 –
Body Mass Index (kg/m2) 32.4 ± 1.4 32.7 ±
(26 – 48) (25 –
Body Fat % (DXA) 46.5 ± 1.7 44.6 ±
(35.9 – 59.9) (30.7 –
Waist Circumference (cm) 100.3 ± 3.6 103.7
(80 – 131) (82 –
Waist: Hip Ratio 0.85 ± 0.02 0.87 ±
(0.75 – 1.01) (0.76 –
Fasting Triglyceride (mmol/L) 1.25 ± 0.17 1.36 ±
(0.48 – 2.6) (0.62 –
Fasting Total Cholesterol (mmol/L) 5.51 ± 0.29 5.83 ±
(2.59 – 7.12) (3.58 –
Fasting HDL Cholesterol (mmol/L) 1.42 ± 0.11 1.38 ±
(0.9 – 2.28) (0.91 –
Fasting LDL Cholesterol (mmol/L) 3.51 ± 0.26 3.89 ±
(1.42 – 5.26) (2.08 –
Fasting Glucose (mmol/L) 5.35 ± 0.13 5.68 ±
(4.55 – 6.22) (4.39 –
HOMA2-IR 1.92 ± 0.28 1.72 ±
(1 – 4.7) (0.9 –
NEFA (mmol/L) 0.51 ± 0.03 0.5 ± 0
(0.3 – 0.79) (0.17 –
Values are mean ± SEM and (range) for n = 64 participants at baseline. BIA: bioelectr
homeostasis model assessment of insulin resistance. NEFA: non-esterified fatty acid5 μg/ml rabbit anti-human apoB antibody in TBST for
60 min. After washing in TBST, membranes were in-
cubated with 0.5 μg/ml donkey anti-rabbit IgG linked to
horseradish peroxidase in TBST for 45 min. After wash-
ing in TBST, membranes were incubated with enhanced
chemiluminescence substrate solution for detection of
horseradish peroxidase and exposed to hyper-film ECL.
The film was developed using an AGFA CP1000 auto-
matic film processor, and apoB48 determined by den-
sitometric scanning using the ScanMaker 9800XL
(Microtek International, USA) scanner and Scion Image
program (Scion Inc).
Post-absorptive energy expenditure
Resting energy expenditure (REE) and respiratory quo-
tient (RQ) were measured in the fasted state for 30 min
at baseline and week 12 by indirect open-circuit calorim-
etry using a ventilator canopy attached to the Deltatrac
II Metabolic Monitor (GE Healthcare). All metabolicic (n = 15) Resistance (n = 16) Combination (n = 17)
3/13 3/14
.2 52 ± 1.1 53 ± 1.3
62) (43 – 59) (43 – 64)
4.1 89.3 ± 4.5 90 ± 4
124.1) (71.9 – 127.5) (62.2 – 122.3)
1.3 33 ± 1.3 33.3 ± 1.2
45.6) (25.8 – 44.6) (23.4 – 40.2)
1.9 43.7 ± 1.3 45.8 ± 1.6
52.5) (34.6 – 52.2) (28.8 – 55.5)
± 2.6 104 ± 3.2 102.2 ± 3.2
118) (83.5 – 135.5) (81.5 – 124.5)
0.02 0.88 ± 0.02 0.86 ± 0.02
1) (0.78 – 1.03) (0.74 – 1.02)
0.19 1.27 ± 0.12 1.1 ± 0.1
3.01) (0.51 – 2.14) (0.48 – 1.91)
0.32 5.49 ± 0.38 5.71 ± 0.31
7.87) (2.92 – 8.95) (3.74 – 9.2)
0.09 1.34 ± 0.08 1.43 ± 0.11
1.99) (0.91 – 2.19) (0.71 – 2.08)
0.3 3.56 ± 0.33 3.78 ± 0.27
6.06) (1.58 – 7.02) (2.4 – 6.88)
0.17 5.81 ± 0.46 5.38 ± 0.13
7.11) (4.91 – 7.17) (4.2 – 6.46)
0.52 1.86 ± 0.18 1.86 ± 0.13
2.5) (0.7 – 3.5) (1.2 – 2.8)
.04 0.49 ± 0.04 0.46 ± 0.03
0.87) (0.18 – 0.94) (0.29 – 0.7)
ical impedance analysis. DXA: dual-energy x-ray absorptiometry. HOMA2-IR:
.
Table 2 Changes in nutritional variables
Baseline Week 8 Week 12
Energy Intake (EI)
Control 7085.1 ± 550.8 7535.6 ± 1197.8 6723.2 ± 585.9
Aerobic 8741.6 ± 1052.7 7471.7 ± 706.7 7179.4 ± 502.3*
Resistance 7776.6 ± 418.0 7234.5 ± 478.0 6937.1 ± 471.6*
Combination 7675.3 ± 324.8 7726.5 ± 428.6 6920.2 ± 402.7
Carbohydrate % of EI
Control 41.8 ± 3.0 42.1 ± 1.8 40.7 ± 2.5
Aerobic 42.5 ± 3.1 44.4 ± 2.6 41.2 ± 2.3
Resistance 40.2 ± 1.6 41.7 ± 1.9 39.4 ± 2.0
Combination 44.2 ± 1.9 44.8 ± 1.9 43.4 ± 1.9
Protein % of EI
Control 18.9 ± 1.5 20.1 ± 1.1 18.5 ± 1.2
Aerobic 18.3 ± 1.3 19.7 ± 1.4 20.8 ± 1.4*
Resistance 19.8 ± 1.1 19.0 ± 0.7 20.2 ± 1.0
Combination 19.1 ± 0.9 18.5 ± 1.0 18.4 ± 1.1
Fat % of EI
Control 33.5 ± 2.2 34.0 ± 1.5 37.1 ± 1.8
Aerobic 35.2 ± 2.6 33.1 ± 1.9 35.1 ± 1.8
Resistance 36.0 ± 1.2 34.8 ± 1.8 36.4 ± 1.4
Combination 33.9 ± 1.7 35.7 ± 1.7 35.7 ± 1.4
SFA % of Fat
Control 41.6 ± 2.1 40.2 ± 1.5 43.6 ± 2.1
Aerobic 41.6 ± 2.3 41.8 ± 1.6 42.5 ± 1.9
Resistance 40.4 ± 1.8 43.3 ± 1.8 42.6 ± 1.0
Combination 45.4 ± 1.6 45.5 ± 1.6 42.8 ± 3.0
MUFA % of Fat
Control 40.6 ± 1.4 41.4 ± 1.1 39.6 ± 1.3
Aerobic 41.3 ± 1.5 39.6 ± 0.8 38.8 ± 1.2
Resistance 39.9 ± 0.9 40.3 ± 1.0 40.8 ± 1.2
Combination 38.9 ± 1.0 39.5 ± 1.0 39.5 ± 1.1
PUFA % of Fat
Control 17.7 ± 1.5 18.4 ± 1.1 16.9 ± 1.4
Aerobic 17.1 ± 1.2 18.4 ± 1.6 18.6 ± 1.8
Resistance 19.6 ± 1.5 16.6 ± 1.2 16.8 ± 1.1
Combination 15.9 ± 1.0 15.2 ± 0.8 17.5 ± 2.4
Values are daily mean± SEM (n = 53) of the nutritional data recorded in 3-day
food diaries at baseline, week 8 and week 12. Statistical significance from
baseline is indicated by * p < 0.05. SFA: saturated fatty acid. MUFA:
monounsaturated fatty acid. PUFA: polyunsaturated fatty acid.
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ology [17] under standardized conditions used in our la-
boratory. Gas calibration was conducted once a day, prior
to any measurements. Before measurements were taken,
participants rested in a supine position for 10–15 min.
Cardio-respiratory fitness assessment
Cardio-respiratory fitness (CRF) was assessed using the
Astrand-Rhyming Submaximal Cycle Ergometer Test
[18] (Monark Exercise AB, Sweden). This was a single-
stage, 6-min test to estimate maximal oxygen consump-
tion (VO2max) from prediction tables of maximal oxygen
consumption at baseline and week 12. A submaximal
protocol was chosen as this method is less stressful and
safer for overweight or obese individuals who are also
sedentary.
Statistical analysis
Sample size calculations were based on a minimum pre-
dicted 15% change in fasting triglyceride and total chol-
esterol levels between the intervention groups, with an
expected standard deviation of 15%. A sample size of 16
participants per group was predicted to provide suffi-
cient power (80%) to detect significant changes at the
5% significance level. However, we aimed to recruit 20
participants per group (a total of 80) to accommodate
for a 20% attrition rate and elimination due to non-
compliance.
Data was assessed for normality to ensure that the
assumptions of the analysis were met. The data for fast-
ing total cholesterol, LDL cholesterol, HDL cholesterol,
triglyceride, glucose, insulin and anthropometric mea-
sures was analysed using General Linear Model to assess
the effects of the groups after adjusting for group and
baseline values. Within-group data was analyzed with
the paired t-test.
When significant between-group effects were present,
post hoc comparisons were made using the LSD
method. Statistical analysis was carried out using SPSS
14.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Participant characteristics at baseline can be seen in
Table 1.
The average daily energy intake from 3-day food diar-
ies at baseline, week 8 and week 12 can be seen in
Table 2. When comparing within-group changes, the
Aerobic and Resistance groups had significantly lower
daily energy intake (EI) at week 12 compared to baseline
(18%, p= 0.041 and 11%, p= 0.039 decrease, respect-
ively). However, there were no significant differences in
total energy intake between groups at week 12. Partici-
pants attended 67-74% of exercise sessions, with no sig-
nificant difference between intervention groups.In the Combination group, change in body weight was
significantly lower compared to Control at week 8 (−1.6%,
p=0.018) and week 12 (−1.6%, p=0.044) and also Resist-
ance group at week 12 (−1.6%, p=0.044) (Figure 2A).
Change in BMI was significantly lower in the Combin-
ation group compared to Control (−1.6%, p= 0.016) and
Resistance (−1.3%, p=0.042) at week 8 and Control (−1.6%,
p=0.040) and Resistance exercise (−1.6%, p=0.042) at
week 12 (Figure 2B). Change in total body fat in the
Figure 2 Comparison of changes from baseline between groups for body weight (A), BMI (B), body fat (C), body fat % (D) and android
fat % (E). Body fat was measured by DXA. Data represents mean± SEM. Statistical differences between groups indicated by different superscripts,
p< 0.05.
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Control (−4.4%, p= 0.003) and Resistance (−3%, p=
0.041) groups at week 12 (Figure 2C). This was also the
case for change in fat percentage, Combination vs. Con-
trol (−2.6%, p= 0.008) (Figure 2D) and for change in an-
droid fat percentage (−2.8%, p= 0.034) (Figure 2E). These
results are also summarised in Table 3.
Table 4 summarises the results for biochemical mar-
kers and energy expenditure. Levels of HDL were signifi-
cantly greater in the Resistance group compared to
Aerobic exercise at weeks 8 and 12. Resistance HDL was
also significantly higher than Control at week 12. In the
Resistance group, apoB48 levels were significantly lower
than in Controls at week 12, 32% (p= 0.04). In the Re-
sistance group, RQ was significantly lower compared to
Control (−4.5%, p= 0.037), Aerobic (−4.9%, p= 0.027)
and Combination (−4.9%, p= 0.022).
VO2max significantly increased in the Combination
group compared to Control (13.3%, p= 0.006) (Figure 3).
Discussion
We have previously demonstrated that a single, moderate-
intensity 30-min bout of aerobic or resistance exerciseimproves risk factors associated with cardiovascular dis-
ease in overweight and obese adults [19], however, fasting
levels of TG, cholesterol, glucose and insulin were not
affected in the short-term. It is possible that some
physiological changes are only seen after a longer period
of training. Thus, we conducted a 12-week chronic study
to explore the impact of aerobic, resistance, or combined
exercise at a moderate-intensity for 30 min, five days/
week. Significant decreases in body weight, BMI and total
body fat were seen in the Combination group compared
to Control and Resistance groups. Similarly, significant
improvements were demonstrated in fat percentage, ab-
dominal fat percentage and cardio-respiratory fitness in
the Combination group compared to Control. Therefore,
moderate-intensity training over 12-weeks using a variety
of training modalities has beneficial effects in CVD risk
factors in overweight and obese individuals compared to
no exercise.
Body weight and BMI in the Combination group were
significantly lower than Control and Resistance groups
at 12 weeks but not Aerobic group. The absence of sig-
nificant decreases in Aerobic and Resistance groups may
have been due to the 30-min moderate-intensity exercise
Table 3 Changes in body measurements and
cardio-respiratory fitness
Weight (kg) Baseline Week 8 Week 12
Control 85.1 ± 4.2 85.5 ± 4.3 85.1 ± 4.3
Aerobic 91.9 ± 4.1 91.1 ± 4.1 91.0 ± 4.0
Resistance 89.3 ± 4.5 89.3 ± 4.3 89.2 ± 4.4
Combination 90.0 ± 4.0 88.8 ± 3.6* 88.4 ± 3.6*
BMI
Control 32.4 ± 1.4 32.5 ± 1.5 32.4 ± 1.5
Aerobic 32.7 ± 1.3 32.5 ± 1.3 32.4 ± 1.2
Resistance 33.0 ± 1.3 33.1 ± 1.3 33.0 ± 1.3
Combination 33.3 ±1.2 33.0 ± 1.1* 32.8 ± 1.1*
Fat (kg)
Control 37.1 ± 2.3 37.3 ± 2.4
Aerobic 39.3 ± 2.5 38.6 ± 2.5
Resistance 37.6 ± 2.3 37.2 ± 2.4
Combination 39.3 ± 1.8 37.7 ± 1.8*
BF%
Control 46.5 ± 1.7 46.7 ± 1.8
Aerobic 44.6 ± 1.9 44.1 ± 1.8
Resistance 43.7 ± 1.3 43.2 ± 1.4
Combination 45.8 ± 1.6 44.8 ± 1.8*
Android Fat %
Control 51.5 ± 1.8 51.7 ± 1.8
Aerobic 50.7 ± 1.6 50.4 ± 1.9
Resistance 49.2 ± 1.3 49.3 ± 1.3
Combination 52.2 ± 1.4 50.9 ± 1.4*
Waist (cm)
Control 100.3 ± 3.6 98.3 ± 3.7* 99.1 ±3.6
Aerobic 103.7 ± 2.6 102.5 ± 2.6 101.6 ± 2.9*
Resistance 104.0 ± 3.2 102.4 ± 3.2 101.4 ± 3.3*
Combination 102.2 ± 3.2 100.5 ± 2.8 99.6 ± 3.0*
VO2max (mL/kg/min)
Control 27.2 ± 1.4 24.9 ± 0.8
Aerobic 24.8 ± 1.1 26.2 ± 0.9
Resistance 24.8 ± 1.8 26.8 ± 0.8
Combination 26.5 ± 1.3 28.2 ± 0.8*
Values are mean ± SEM (n=64) at baseline, week 8 and week 12. Statistical
significance from baseline is indicated by * p < 0.05.
Table 4 Changes in fasting blood measurements, resting
energy expenditure and respiratory quotient
Baseline Week 8 Week 12
TG (mmol/L)
Control 1.25 ± 0.17 1.37 ± 0.19 1.48 ± 0.23
Aerobic 1.36 ± 0.19 1.29 ± 0.11 1.40 ± 0.16
Resistance 1.27 ± 0.12 1.21 ± 0.16 1.38 ± 0.18
Combination 1.10 ± 0.10 1.08 ± 0.10 1.36 ± 0.17*
TC (mmol/L)
Control 5.51 ± 0.29 5.88 ± 0.32 5.49 ± 0.28a
Aerobic 5.83 ± 0.32 5.72 ± 0.29 5.56 ± 0.37a
Resistance 5.49 ± 0.38 5.76 ± 0.36 6.15 ± 0.44* b
Combination 5.71 ± 0.31 5.74 ± 0.27 5.75 ± 0.26ab
HDL (mmol/L)
Control 1.42 ± 0.11 1.45 ± 0.11ab 1.35 ± 0.10a
Aerobic 1.38 ± 0.09 1.31 ± 0.08a 1.28 ± 0.07* a
Resistance 1.34 ± 0.08 1.44 ± 0.08b 1.44 ± 0.08* b
Combination 1.43 ± 0.11 1.44 ± 0.10ab 1.41 ± 0.11ab
LDL (mmol/L)
Control 3.51 ± 0.26 3.79 ± 0.31 3.47 ± 0.25a
Aerobic 3.89 ± 0.30 3.82 ± 0.27 3.64 ± 0.33a
Resistance 3.56 ± 0.33 3.76 ± 0.31 4.08 ± 0.36* b
Combination 3.78 ± 0.27 3.80 ± 0.22 3.71 ± 0.22a
NEFA (mmol/L)
Control 0.51 ± 0.03 0.45 ± 0.04a 0.48 ± 0.03
Aerobic 0.50 ± 0.04 0.59 ± 0.05b 0.47 ± 0.04
Resistance 0.49 ± 0.04 0.52 ± 0.04ab 0.54 ± 0.05
Combination 0.46 ± 0.03 0.49 ± 0.03ab 0.54 ± 0.04
Glucose (mmol/L)
Control 5.35 ± 0.13 5.46 ± 0.10 5.26 ± 0.18
Aerobic 5.68 ± 0.17 5.78 ± 0.18 5.73 ± 0.10
Resistance 5.81 ± 0.46 5.81 ± 0.17 5.77 ± 0.16
Combination 5.38 ± 0.13 5.31 ± 0.10 5.55 ± 0.13
Insulin (μUI/mL)
Control 14.89 ± 2.29 14.82 ± 1.66 14.76 ± 1.69
Aerobic 13.05 ± 1.01 16.67 ± 1.48* 15.87 ± 1.86
Resistance 13.98 ± 1.40 16.82 ± 1.33* 13.48 ± 1.24
Combination 14.24 ± 1.03 17.07 ± 1.33* 14.25 ± 1.25
ApoB48 (μg/mL)
Control 6.75 ± 0.74 6.23 ± 0.58 7.08 ± 0.77a
Aerobic 5.68 ± 0.59 5.57 ± 0.78 5.58 ± 0.77ab
Resistance 5.92 ± 1.05 4.54 ± 0.64 4.46 ± 0.45* b
Combination 5.30 ± 0.56 5.33 ± 0.82 5.04 ± 0.78ab
REE (kJ/day)
Control 6088.4 ± 392.7 6081.9 ± 384.8
Aerobic 6388.2 ± 281.2 6283.5 ± 264.6
Resistance 6468.3 ± 312.1 6431.2 ± 302.5
Combination 6328.2 ± 319.7 6252.1 ± 291.1
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ported in other studies [3,20-24]. However, Park et al.
[20] also found that combination exercise was more ef-
fective for body composition improvements than aerobic
exercise alone.
The Combination intervention produced the greatest
improvements in body composition, significant decreases
in total body fat, fat percentage, android fat percentage
and gynoid fat percentage. Park et al. [20] also observed
that combination exercise was more effective in decreas-
ing visceral fat than aerobic exercise. High levels of fat,
Table 4 Changes in fasting blood measurements, resting
energy expenditure and respiratory quotient (Continued)
RQ
Control 0.84 ± 0.007 0.84 ± 0.012
Aerobic 0.84 ± 0.010 0.84 ± 0.014
Resistance 0.85 ± 0.016 0.81 ± 0.016*
Combination 0.83 ± 0.023 0.84 ± 0.017
Values are mean ± SEM (n = 64) of fasting blood measurements at baseline,
week 8 and week 12. Statistical significance from baseline (within groups) is
indicated by * p< 0.05. Statistical differences between groups at week 8 or 12
with baseline as a covariate indicated by different superscripts p< 0.05. TG:
triglyceride. TC: total cholesterol. HDL: high density lipoprotein. LDL: low
density lipoprotein. NEFA: non-esterified fatty acid. ApoB48: apolipoprotein
B48. REE: resting energy expenditure. RQ: respiratory quotient.
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http://www.biomedcentral.com/1471-2458/12/704especially in the abdomen, increase the risk of developing
Type 2 diabetes and CVD [25], thus combination exer-
cise training can be beneficial in reducing this risk.
Interestingly, a similar study by Church et al. [8] ob-
served a significant decrease in body mass in the Com-
bination group compared to Control and Resistance
groups after 9 months of training, comparable to our
findings. This indicates that the effects of aerobic and re-
sistance exercise interact to have a greater effect than ei-
ther type alone. However, the mechanisms involved are
unclear and further investigations are warranted.
We did not observe any significant reduction in lipids,
glucose or insulin after 12 weeks of training, which is in-
consistent with previous studies. Generally, those studies
involved higher levels of exercise [20,26]. ApoB48 was
significantly lower after training in the Resistance group
compared to Control but not compared to aerobic and
combination exercise. Changes to apoB48 were not
reported in other studies investigating the effects of ex-
ercise training. As apoB48 is a marker for chylomicron
particles, a decrease indicates a lower number of parti-
cles circulating in the blood, which is associated with
decreased risk of atherosclerosis [27].
We observed a small but significant decrease in the
RQ in the Resistance group. Other studies have demon-
strated a decrease in resting non-protein RQ in olderFigure 3 Comparison of changes from baseline between
groups for cardio-respiratory fitness. Values are mean± SEM
(n = 64). Statistical differences between groups indicated by different
superscripts, p< 0.05.women after 16 weeks resistance training [28] indicating
a shift in substrate utilization to increased lipid oxida-
tion for energy. A hypocaloric diet also decreases the
RQ and increases fat oxidation [29]. This matches our
observation of a significant decrease in energy intake in
the Aerobic and Resistance groups at week 12. This
change in substrate utilization may have a beneficial im-
pact on body fat and obesity in the long-term.
We observed a significant increase in estimated max-
imum oxygen uptake (VO2max) in the Combination group.
Greater cardio-respiratory fitness has long been asso-
ciated with decreased risk of disease and death [30-32].
Obese individuals with higher fitness levels generally have
lower mortality rates compared to sedentary normal-
weight counterparts [33]. Previous studies have shown
increases in VO2max from baseline levels after resistance
exercise training [34] and combined aerobic and resist-
ance exercise training [7,8,33]. In our study, a moderate-
intensity of 60% of estimated HRR was used for aerobic
exercise to target greater fat oxidation rather than cardio-
respiratory fitness improvements per se [35]. Combination
training was more effective at increasing cardio-
respiratory fitness compared to Control but not aerobic
and resistance training. The lack of improvement in the
Aerobic group was possibly due to variability in partici-
pants. Whilst most participants displayed an increase in
cardio-respiratory fitness level, some showed a reduction
in cardio-respiratory fitness level (mean −5.3 mL/kg/min,
n = 3) despite the training. Participant factors such as
stress, anxiety and time since the last exercise session
may have affected the test results. Cardio-respiratory fit-
ness levels in the Aerobic group may eventually have
increased significantly given a longer training period,
such as that by Church et al., [36] which employed a six
month intervention. However, our Combination in-
tervention demonstrates that improvements in cardio-
respiratory fitness in the overweight and obese can be
achieved following the Australian physical activity
recommendations.
The present study had a number of limitations. Partici-
pants were mainly female despite a higher prevalence of
overweight and obesity in males in Australia [37]. Due
to limited sample size, our study may have been under-
powered to detect significant changes in some variables.
As several groups of participants were staggered over a
15–month period, seasonal changes may have been a
factor [38]. Reported energy intake in all groups
decreased over the course of the intervention and this
may have contributed to changes in body weight and
composition. Monitoring the intensity and frequency of
exercise was another challenge. Despite the completion
of exercise diaries and regular contact with the re-
searcher, we were reliant on participant honesty and ac-
curacy in their self-reported information. If participants
Ho et al. BMC Public Health 2012, 12:704 Page 9 of 10
http://www.biomedcentral.com/1471-2458/12/704in the aerobic group did not complete the prescribed ex-
ercise this may explain the lack of improvements in the
current study.
Conclusion
A 12-week training program of resistance or combined
exercise at a moderate-intensity for 30-min, five days/
week resulted in unique improvements to the cardiovas-
cular risk profile in overweight and obese participants
compared to no exercise. Currently, there are no specific
recommendations for the type of exercise the overweight
and obese should engage in. From our observations,
combination exercise gave greater benefits for weight
loss, fat loss and cardio-respiratory fitness than aerobic
and resistance training modalities. Therefore, combin-
ation exercise training should be recommended for over-
weight and obese adults in National Physical Activity
Guidelines.
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